Thank you, Jason. Let me begin with our financial results for the quarter. As Phil noted, adjusted net investment income was $0.36 per share for the fourth quarter and $1.52 per share for the full year 2024. As detailed in our earnings press release, adjusted net investment income excludes amortization of the purchase accounting discount resulting from our merger with BCIC and is calculated in accordance with GAAP. A full reconciliation of adjusted net investment income to GAAP net investment income, as well as other non-GAAP financial metrics, is included in our earnings release and 10-K. Gross investment income for the fourth quarter was $072 per share. This amount included recurring cash interest of $0.52 nonrecurring income of $0.06, recurring discount and fee amortization of $0.03, PIC income of $0.08 and dividend income of $0.03 per share. Fixed interest income for the quarter was 10.5% of total investment income. Operating expenses for the fourth quarter were $0.32 per share and included $0.21 per share of interest and other debt expenses. As of December 31, 2024, the Company's cumulative total return did not exceed the total return hurdle. And as a result, no incentive compensation was accrued for the three months ended December 31, 2024. Additionally, as Phil mentioned, our advisor has agreed to waive 1/3 of our base management fees for three quarters beginning on January 1, 2025, and ending on September 30, 2025. Net realized losses for the quarter were approximately $3,000 or less than $0.01 per share. Net unrealized losses in the fourth quarter totaled $72 million or $0.85 per share, primarily reflecting unrealized markdowns on the three investments Phil discussed earlier. The net decrease in net assets for the quarter was $80 million or $0.89 per share. As of December 31, 12 portfolio companies were on non-accrual status, representing 5.6% of the portfolio at fair value and 14.4% at cost. As Phil noted, we are working closely with our borrowers, their creditors and sponsors to resolve issues with the best possible outcomes for our shareholders. The remainder of our portfolio is performing well. Turning to our liquidity. Our balance sheet position remains solid, and our total liquidity increased to $615 million at quarter end with $519 million of available leverage and $92 million in cash. Unfunded loan commitments to portfolio companies at year end were 8% of our $1.8 million investment portfolio or approximately $144 million including only $62 million of revolver commitments. Net regulatory leverage at the end of the quarter was 1.14x which is within our target range of 0.9x to 1.2x. We have ample financing options to fund new investments with our diverse and flexible leverage program, which includes three low-cost credit facilities, three unsecured note issuances and an SBA program. The weighted average interest rate on debt outstanding at the end of the quarter was 5.2%, down from 5.4% at the end of the prior quarter. Now, I'll turn the call back over to the operator to open the line up for questions.